This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Sherine E. Gabriel, MD, MSc
Rochester, Minn

Arch Intern Med. 1995;155(13):1448-1451.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In the recent review article, "Is Misoprostol Cost-effective in the Prevention of Nonsteroidal Anti-inflammatory Drug—Induced Gastropathy in Patients With Chronic Arthritis?" Stucki et al¹ overlooked an important criticism regarding the calculation of the probability of gastrointestinal tract hemorrhage that appeared in an article by Edelson et al.² In that study, the probability estimates for gastrointestinal tract hemorrhage for the "overall" category were derived using an estimate of population attributable fraction (PAF). The PAF is defined as the proportion of all cases (upper gastrointestinal tract hemorrhage) in the target population attributable to the exposure (nonsteroidal anti-inflammatory drugs) (NSAIDs).³ The prevalence of the exposure in the target population and the relative risk of the exposure determine the PAF, ie, PAF=p_e(RR — 1)/p_e(RR — 1) + 1, where p_e is the prevalence of exposure to NSAIDs and RR is the relative risk of gastrointestinal tract hemorrhage . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?